Rated pharmaceutical companies Adjusted cash and debt, $US billions Source: Moody’s Investors Service, April 2010
Rated pharmaceutical companies Adjusted cash and debt, $US billions Source: Moody’s Investors Service, April 2010
Credit: 
3206DSN_ChainPharmacy5-fig2.jpg